Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients.
Conditions
- Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)
- Smell Loss
Interventions
- DRUG: Dupilumab - Standard Dose
Sponsor
Northwestern University
Collaborators